Emily Chiu

Honors and Awards:

• Ruth L. Kirschstein National Research Service Award for Predoctoral MD/PhD Fellows, National Cancer Institiute, 2019-2022

Thesis Advisor: Jeff Miller, M.D.

Publications

Chiu E, Felices M, Cichocki F, Davis Z, Wang H, Tuninga K, Vallera DA, Lee T, Bjordahl R, Malmberg KJ, Valamehr B, Miller JS. Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C + NK cells to target myeloid leukemia. Mol Ther. 2021 Dec 1;29(12):3410-3421. PMCID: PMC8636174

Work prior to the UMN MSTP:

Cook JR, Clayton NP, Carta L, Galatioto J, Chiu E, Smaldone S, Nelson CA, Cheng SH, Wentworth BM, Ramirez F. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome. Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):911-7. PMCID: PMC4376614

Cook JR, Carta L, Bénard L, Chemaly ER, Chiu E, Rao SK, Hampton TG, Yurchenco P; GenTAC Registry Consortium., Costa KD, Hajjar RJ, Ramirez F. Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome. J Clin Invest. 2014 Mar;124(3):1329-39. PMCID: PMC3934180

Galatioto J, Chiu E, Cook JR. Marfan syndrome: Exploring new options in management. Drugs of the Future. 2014;39(7):479-485.